Physician
Hao Wei Zhang M.D., INC.
Hao Wei Zhang M.D., INC. was paid $1.41M by Medicaid between Jan 2018 and Nov 2024, across 30 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 33% of everything it billed.
33Billing provider infoHAO WEI ZHANG M.D., INC.
LOS ANGELES, CA 90033
LOS ANGELES, CA 90033
33aNPI1548361413assigned 09/25/2006
33bProvider typeHematology & Oncology Physician
28Total paid$1.41M
24GClaims43,058
24DCodes billed30
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Hematology & Oncology Physician providers in California
Rank by total paid#13 of 180
Median peer was paid$26K
This provider vs. median55×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 11,047 | $296K | |
| 2019 | 11,098 | $285K | |
| 2020 | 3,850 | $212K | |
| 2021 | 4,427 | $251K | |
| 2022 | 4,257 | $147K | |
| 2023 | 4,191 | $134K | |
| 2024incomplete | 4,188 | $87K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 33% | 8,138 | 7,418 | $462K |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 20% | 11,766 | 2,388 | $287K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 8.3% | 3,030 | 2,875 | $117K |
| J2820 | Injection, sargramostim (gm-csf), 50 mcg | 6.2% | 197 | 36 | $87K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 4.6% | 1,620 | 878 | $65K |
| 99223 | Prolong inpt eval add15 m | 3.8% | 831 | 800 | $53K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 3.7% | 2,041 | 1,187 | $53K |
| Q5112 | Injection, trastuzumab-dttb, biosimilar, (ontruzant), 10 mg | 3.5% | 16 | 12 | $50K |
| 96375 | Therapeutic injection; each additional sequential IV push | 2.8% | 1,265 | 676 | $40K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.1% | 1,676 | 524 | $30K |
| J1447 | Injection, tbo-filgrastim, 1 microgram | 1.7% | 136 | 12 | $24K |
| 96417 | 1.2% | 733 | 494 | $17K |
18 more codes
| J7050 | Infusion, normal saline solution, 250 cc | 1.2% | 3,569 | $16K |
| J1626 | Injection, granisetron hydrochloride, 100 mcg | 1.1% | 1,827 | $15K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 911 | $14K |
| J9070 | Cyclophosphamide, 100 mg | <1% | 33 | $13K |
| 96367 | <1% | 532 | $12K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 149 | $10K |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | <1% | 1,521 | $9K |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 772 | $9K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,103 | $8K |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 206 | $7K |
| 96402 | <1% | 326 | $3K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 74 | $2K |
| 96415 | <1% | 74 | $2K | |
| J9267 | Injection, paclitaxel, 1 mg | <1% | 56 | $1K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 22 | $1K |
| J9045 | Injection, carboplatin, 50 mg | <1% | 24 | $984.66 |
| J2469 | Injection, palonosetron hcl, 25 mcg | <1% | 23 | $833.14 |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 387 | $528.25 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialZHANG, HAO (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Edison Wellness Medical Group PA | Edison, NJ | $16K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.